Latest It Consulting News

Genetic Technologies Limited has emerged from voluntary administration following a strategic asset sale and is now pursuing recapitalisation and acquisitions to restore its market position.

Invion Limited has disclosed that the US FDA granted Orphan Drug Designation for its lead cancer drug candidate INV043, explaining recent unusual trading activity in its shares. The company confirmed it was unaware of the FDA decision prior to its public release and has now complied with continuous disclosure rules.

Duxton Farms has received Foreign Investment Review Board approval for its strategic merger and updated its timetable for key shareholder and court approvals, alongside a $4.55 million capital raise.

RocketBoots Limited has secured a significant trial contract with one of Mexico's largest retail banks, marking a key step in its international expansion and potential revenue growth.

Novomatic AG has launched an unconditional A$1.00 per share cash takeover offer for all remaining shares in Ainsworth Game Technology Limited, representing a 35% premium to pre-announcement prices. The offer runs alongside a previously announced scheme and comes with unanimous support from Ainsworth's Independent Board Committee.

Opthea Limited has terminated its sozinibercept wet AMD program following Phase 3 trial failures and settled a major funding agreement, setting the stage for a strategic reset.

StepChange Holdings has reported FY25 results that beat expectations, following its acquisition of StepChange Consultants and successful ASX listing. The company sets a promising stage for FY26 with strong operational momentum.

StepChange Holdings Limited reported a $2.69 million loss for its inaugural financial period ending June 2025, completed a significant $18.3 million acquisition, and successfully listed on the ASX in July 2025.

Transurban Group’s FY25 results reveal a complex financial picture with statutory profit halving but operational EBITDA and toll revenues rising, supported by key infrastructure projects nearing delivery.

Transurban Group reported a 5.6% rise in proportional toll revenue and a 7.4% increase in operating EBITDA for FY25, despite a significant profit decline due to litigation and restructuring costs. The company’s distribution grew 4.8%, supported by strong free cash flow, as key infrastructure projects near completion.

Felix Group Holdings reports a solid 22% increase in FY25 sales revenue and a notable 32% improvement in adjusted EBITDA loss, driven by strong enterprise platform sales and new customer wins.

Felix Group Holdings has announced a strategic acquisition of Nexvia, a Brisbane-based SaaS platform, boosting its pro-forma ARR by 38% and launching a $17 million capital raising to fund the deal and growth initiatives.